Vascular targeting as a strategy for cancer therapy.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 9700184)

Published in N Engl J Med on August 13, 1998

Authors

J E Schnitzer1

Author Affiliations

1: Harvard Medical School, Boston, MA 02115, USA.

Articles citing this

Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54

CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol (2004) 1.57

Screening phage display libraries for organ-specific vascular immunotargeting in vivo. Proc Natl Acad Sci U S A (2005) 1.46

Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci U S A (2002) 1.43

Endothelial targeting of antibody-decorated polymeric filomicelles. ACS Nano (2011) 1.03

Enhancing identifications of lipid-embedded proteins by mass spectrometry for improved mapping of endothelial plasma membranes in vivo. Mol Cell Proteomics (2009) 0.99

Endothelial cell culture: beginnings of modern vascular biology. J Clin Invest (2004) 0.97

Targeted modulation of reactive oxygen species in the vascular endothelium. J Control Release (2011) 0.97

Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo. J Biol Chem (2009) 0.95

Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo. Am J Physiol Lung Cell Mol Physiol (2009) 0.92

Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano (2014) 0.92

Levamisole induced apoptosis in cultured vascular endothelial cells. Br J Pharmacol (2000) 0.88

Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours. Br J Cancer (2009) 0.87

Targeted interception of signaling reactive oxygen species in the vascular endothelium. Ther Deliv (2012) 0.87

Diverse responses to vascular disrupting agent combretastatin a4 phosphate: a comparative study in rats with hepatic and subcutaneous tumor allografts using MRI biomarkers, microangiography, and histopathology. Transl Oncol (2013) 0.86

Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications. J Cancer (2013) 0.85

Oral thrombostatin FM19 inhibits prostate cancer. Thromb Haemost (2010) 0.82

Antibody library-based tumor endothelial cells surface proteomic functional screen reveals migration-stimulating factor as an anti-angiogenic target. Mol Cell Proteomics (2008) 0.81

Preconditioning serum levels of endothelial cell-derived molecules and the risk of posttransplant complications in patients treated with allogeneic stem cell transplantation. J Transplant (2014) 0.79

Age-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophen. Microvasc Res (2012) 0.77

Targeted endothelial nanomedicine for common acute pathological conditions. J Control Release (2015) 0.77

Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapy. Invest New Drugs (2012) 0.76

IgA and IgM protein primarily drive plasma corona-induced adhesion reduction of PLGA nanoparticles in human blood flow. Bioeng Transl Med (2017) 0.75